Boundless Bio Inc
For the period ended Mar 31, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information.
Rule 10b5-1 Trading Arrangements
From time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into or terminate Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended March 31, 2025, our officers or directors adopted, modified, or terminated such trading arrangements as set forth below.
| Action · Date · Trading Arrangement | |||||
|---|---|---|---|---|---|
| Rule 10b5-1* · Non-Rule 10b5‑1** · Total Shares Subject to Plan · Expiration Date | |||||
| Neil Abdollahian, former Chief Business Officer(1) | Terminate | January 29, 2025 | X | 32,537(2) | Not applicable |
| ____________________* Intended to satisfy the affirmative defense of Rule 10b5-1(c)** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)(1)Mr. Abdollahian’s employment ended on January 10, 2025.(2)No sales occurred pursuant to this trading plan prior to its termination. | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.